Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: AMZN TGT WMT COST BBY DG DLTR M KSS JWN

| Held by: VTI IWM VB VBK IWO VXF SCHA JTEK VTWO DFAC

Index	RUT	P/E	-	EPS (ttm)	-0.08	Insider Own	19.22%	Shs Outstand	105.01M	Perf Week	2.81%
Market Cap	3.26B	Forward P/E	54.45	EPS next Y	0.49	Insider Trans	-1.26%	Shs Float	98.51M	Perf Month	-0.22%
Enterprise Value	3.20B	PEG	-	EPS next Q	0.09	Inst Own	81.35%	Short Float	9.27%	Perf Quarter	19.10%
Income	-9.23M	P/S	3.97	EPS this Y	5.56%	Inst Trans	3.01%	Short Ratio	5.28	Perf Half Y	31.90%
Sales	821.35M	P/B	9.03	EPS next Y	51.64%	ROA	-1.40%	Short Interest	9.13M	Perf YTD	10.49%
Book/sh	2.96	P/C	11.39	EPS next 5Y	23.68%	ROE	-2.67%	52W High	29.73 -10.02%	Perf Year	92.72%
Cash/sh	2.35	P/FCF	62.30	EPS past 3/5Y	50.37% 19.99%	ROIC	-1.63%	52W Low	13.63 96.26%	Perf 3Y	99.18%
Dividend Est.	-	EV/EBITDA	97.78	Sales past 3/5Y	12.56% 15.80%	Gross Margin	52.43%	Volatility	2.81% 2.91%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.90	EPS Y/Y TTM	80.34%	Oper. Margin	-2.14%	ATR (14)	0.91	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.21	Sales Y/Y TTM	14.09%	Profit Margin	-1.12%	RSI (14)	57.12	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.53	EPS Q/Q	74.60%	SMA20	1.04%	Beta	2.11	Target Price	26.08
Payout	-	Debt/Eq	0.63	Sales Q/Q	13.95%	SMA50	7.81%	Rel Volume	0.89	Prev Close	27.55
Employees	3780	LT Debt/Eq	0.56	Earnings	Aug 07 BMO	SMA200	19.35%	Avg Volume	1.73M	Price	26.75
IPO	Sep 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.24% 0.64%	Trades		Volume	1,533,886	Change	-2.90%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-01-25	Reiterated	Telsey Advisory Group	Outperform	$22 → $28
Jul-10-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Apr-30-25	Upgrade	Citigroup	Sell → Neutral	$17
Apr-17-25	Upgrade	Loop Capital	Hold → Buy	$27
Feb-28-25	Reiterated	Telsey Advisory Group	Outperform	$28 → $30
Feb-25-25	Initiated	ROTH MKM	Neutral	$26
Feb-05-25	Downgrade	Citigroup	Neutral → Sell	$19 → $23
Jan-17-25	Downgrade	Evercore ISI	Outperform → In-line	$23
Nov-19-24	Reiterated	Telsey Advisory Group	Outperform	$22 → $26
Nov-08-24	Reiterated	Telsey Advisory Group	Outperform	$19 → $22
Nov-07-24	Upgrade	William Blair	Mkt Perform → Outperform
Oct-21-24	Upgrade	Goldman	Neutral → Buy	$15 → $18
Aug-23-24	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$20
Aug-23-24	Resumed	Piper Sandler	Overweight	$18
Oct-12-23	Upgrade	BTIG Research	Neutral → Buy	$17
Oct-03-23	Upgrade	Evercore ISI	In-line → Outperform	$20
Sep-25-23	Initiated	UBS	Neutral	$13
Jun-27-23	Initiated	William Blair	Mkt Perform
May-24-23	Initiated	JMP Securities	Mkt Perform
Mar-01-23	Downgrade	Citigroup	Buy → Neutral	$26 → $13

Show Previous Ratings

Sep-11-25 09:00AM	Warby Parker (WRBY) Rose Following the Partnership Announcement with Google (Insider Monkey)
Sep-05-25 04:23PM	Time to Buy? (Motley Fool)
Aug-28-25 04:05PM	Warby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing Conference (Business Wire)
Aug-27-25 10:27PM	Eyewear giant Warby Parker has a huge new sports partnership (TheStreet)
09:00AM	Warby Parker Teams Up with Arch Manning for Three-Year Partnership (Business Wire)
04:45PM	Loading…
Aug-14-25 04:45PM	Warby Parker, Tilly's, Advance Auto Parts, RH, and Victoria's Secret Shares Plummet, What You Need To Know (StockStory)
01:33AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q2 Earnings Call (StockStory)
Aug-13-25 12:05PM	Drivepoint Adds $9M From Top Tech And Consumer Investors To Accelerate AI Finance Platform For Retail Brands (PR Newswire) +9.83%
11:24AM	Direct-to-consumer IPOs go from boom to bust (Financial Times)
Aug-12-25 09:58AM	2 Stocks Under $50 Worth Your Attention and 1 Facing Challenges (StockStory) +5.12%
03:22AM	WRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the Quarter (StockStory)
Aug-11-25 04:45AM	Tariffs Test Warby Parkers Affordable Glasses Strategy (The Wall Street Journal)
Aug-10-25 05:30AM	How Warby Parker Has Kept the Price of Glasses at $95 for 15 Years (The Wall Street Journal)
Aug-07-25 02:32PM	Warby Parker's (NYSE:WRBY) Q2 Sales Top Estimates (StockStory)
09:30AM	Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics (Zacks)
08:05AM	Loading…
08:05AM	Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates (Zacks)
07:27AM	Warby Parker to end home try-on program as it focuses on stores, digital experience (Retail Dive)
06:45AM	Warby Parker Announces Second Quarter 2025 Results (Business Wire)
Aug-06-25 07:10AM	National Vision (EYE) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 11:02PM	What To Expect From Warby Parker's (WRBY) Q2 Earnings (StockStory)
Aug-01-25 01:56PM	Warby Parker, Petco, Tilly's, Abercrombie and Fitch, and RH Shares Plummet, What You Need To Know (StockStory)
07:15AM	Newell Brands (NWL) Q2 Earnings Match Estimates (Zacks)
Jul-31-25 05:25PM	Clorox (CLX) Q4 Earnings and Revenues Top Estimates (Zacks)
10:00AM	Warby Parker Inc. (WRBY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-23-25 10:00AM	Nordstrom Rack to Open New Location in Mansfield, MA (PR Newswire)
Jul-17-25 06:05PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
04:05PM	Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025 (Business Wire)
Jul-09-25 10:31AM	Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. (Barrons.com)
08:25AM	Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. (Barrons.com)
Jul-08-25 03:13PM	Meta Invests $3.5 Billion in Worlds Largest Eye-Wear Maker in AI Glasses Push (Bloomberg)
11:32PM	Loading…
Jul-07-25 11:32PM	Winners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
02:33PM	Q&A: Warby Parker retail and experience chief talks store evolution, expansion (Chain Store Age)
Jul-04-25 05:30AM	American Companies Hit the Brakes on Hiring (The Wall Street Journal)
05:30AM	American Companies Had Lowest Job Growth in Eight Months (The Wall Street Journal)
Jun-30-25 08:29AM	What Makes Warby Parker (WRBY) an Attractive Investment? (Insider Monkey)
Jun-27-25 08:06AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q1 Earnings Call (StockStory)
Jun-20-25 01:52PM	Meta and Oakley Are Launching AI-Powered Glasses This Summer (Investopedia)
Jun-19-25 12:05AM	Warby Parker (WRBY): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-18-25 09:30AM	Grifin Raises $11M Series A to Make Investing as Easy--And Automatic--as Everyday Spending (PR Newswire)
Jun-16-25 03:33PM	Warby Parkers Latest Vision (WWD)
Jun-13-25 10:02AM	RH Q1 Earnings Top Estimates, Revenues Miss, Margins Up Y/Y (Zacks)
Jun-09-25 10:32AM	Was Jim Cramer Right to Be Cautiously Bullish on Warby Parker (WRBY) Last Year? (Insider Monkey)
07:18AM	WRBY Q1 Earnings Call: Management Details Tariff Mitigation, Store Expansion, and Pricing Actions (StockStory)
Jun-02-25 07:00AM	Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference (Business Wire)
May-29-25 09:12AM	Warby Parker partners with Google, adds AI shopping assistant (Retail Dive)
May-28-25 11:57AM	Warby Parker personalizes frame recommendations with AI (Chain Store Age)
May-27-25 09:31PM	It's Unofficially Summer. Time to Get Outside, and Talk With Decking Expert Trex CEO Bryan Fairbanks (Motley Fool)
03:34PM	Loop Capital Maintains Buy Rating on Warby Parker (WRBY) Stock (Insider Monkey)
May-23-25 12:16PM	Warby Parker (WRBY) Joins AI Race, Google Backs Smart Glasses Project (Insider Monkey)
08:38AM	Can Warby Parker & Google crack the smart glasses code? (Chain Store Age)
May-22-25 01:40PM	Google is teaming up with Warby Parker to develop AI powered smart glasses (CNBC TV)
09:39AM	Warby Parker co-founder Neil Blumenthal: Smart glasses will be transformative to our lives (CNBC TV)
May-21-25 04:34PM	TD Cowen Maintains a Buy Rating on Warby (WRBY) After Google Partnership (Insider Monkey)
May-20-25 11:51PM	Why Warby Parker Inc. (WRBY) Skyrocketed Today (Insider Monkey) +15.63%
06:57PM	Why Warby Parker Stock Raced 16% Higher on AI News Tuesday (Motley Fool)
05:58PM	Google Partners With Warby Parker, Kering to Develop AI Glasses (The Wall Street Journal)
03:50PM	3 takeaways from Alphabet's AI-focused Google I/O 2025 (Yahoo Finance Video)
03:37PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
03:27PM	Warby Parker teams with Google to develop AI-enabled glasses (Chain Store Age)
02:53PM	Warby Parker Stock Pops on Partnership With Google to Develop AI Glasses (Barrons.com)
01:58PM	Warby Parker Partners with Google To Develop Intelligent Eyewear (Business Wire)
01:45PM	Google announces smart glasses partnerships as it takes on Meta, Apple preps its own eyewear (Yahoo Finance)
May-15-25 10:17AM	Walmart earnings: Why it's 'one of the best-positioned retailers' (Yahoo Finance Video)
May-13-25 03:39PM	Are Options Traders Betting on a Big Move in Warby Parker (WRBY) Stock? (Zacks)
May-11-25 11:49AM	How some early feedback put Warby Parker on the path to success (Yahoo Finance)
May-10-25 10:58AM	Warby Parker price target lowered to $22 from $30 at Telsey Advisory (TipRanks)
May-09-25 03:13AM	Warby Parker Inc (WRBY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -5.23%
May-08-25 11:38PM	Warby Parker Inc. (WRBY): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey)
02:35PM	Warby Parker post quarterly profit first since going public in 2021 (Chain Store Age)
09:30AM	Warby Parker (WRBY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:31AM	Warby Parker posts first quarterly net profit since going public (Retail Dive)
08:00AM	Warby Parker Inc. (WRBY) Matches Q1 Earnings Estimates (Zacks)
06:45AM	Warby Parker Announces First Quarter 2025 Results (Business Wire)
May-07-25 10:07AM	Warby Parker Inc (WRBY) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:15AM	National Vision (EYE) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:46AM	Warby Parker Inc. (WRBY): Among Richard Chilton's Stock Picks with Huge Upside Potential (Insider Monkey)
May-06-25 05:55PM	Purple Innovation (PRPL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-02-25 09:30PM	KITS Eyecare: Strong Moat, Expanding Growth Runway, And A Prime Acquisition Target (Seeking Alpha)
Apr-30-25 06:01AM	Down More Than 30%: Analysts Say Scoop Up These 2 Beaten-Down Stocks Before They Bounce Back (TipRanks)
Apr-29-25 09:02AM	1 Unprofitable Stock with Competitive Advantages and 2 to Question (StockStory)
Apr-25-25 05:01AM	A Look Back at Specialty Retail Stocks' Q4 Earnings: Warby Parker (NYSE:WRBY) Vs The Rest Of The Pack (StockStory)
Apr-17-25 04:05PM	Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Apr-10-25 09:23AM	Warby Parker (WRBY) Soars 15.8%: Is Further Upside Left in the Stock? (Zacks) -8.23%
Apr-04-25 01:50PM	It Looks Like Buffett Was Right: Stocks Crushed As Recession Odds Hit 56%, What's Next? (Seeking Alpha)
Apr-01-25 05:02AM	2 Reasons to Watch WRBY and 1 to Stay Cautious (StockStory)
Mar-31-25 01:43PM	Morgan Stanley Says Tariffs May Put Footwear, Apparel Importers in Tight Spot (Investopedia)
Mar-26-25 04:08AM	EssilorLuxottica: Quality Company, Here For The Long Haul (SeekingAlpha)
Mar-21-25 10:20AM	TimesSquare Global Small Cap Strategy Q4 2024 Commentary (SeekingAlpha)
04:30AM	Lazard US Small Cap Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 04:45AM	Strength Seen in Warby Parker (WRBY): Can Its 6.6% Jump Turn into More Strength? (Zacks)
Mar-19-25 09:30AM	Why Warby Parker Inc. (WRBY) Crashed On Tuesday? (Insider Monkey) +6.62%
Mar-05-25 05:30AM	Target Wants to Bring Back the Tarzhay Magic (The Wall Street Journal)
Mar-01-25 10:15AM	Warby Parker price target raised to $30 from $28 at Telsey Advisory (TipRanks)
Feb-28-25 11:41AM	Warby Parker pushes CX investments in-store and online (CX Dive)
02:11AM	Warby Parker Inc (WRBY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-27-25 08:33PM	Target announces major deal to win back shoppers (TheStreet)
05:00PM	Warby Parker to open eyewear shops in Target stores: Heres the full list of locations coming in 2025 (FastCompany)
03:30PM	Warby Parker (WRBY) Q4 2024 Earnings Call Transcript (Motley Fool)
12:38PM	Warby Parker Makes the Jump to Target (WWD)
10:32AM	Warby Parker to open in-store shops at Target (Chain Store Age)

Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NEIL BLUMENTHAL	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
David Gilboa	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
Cutler Joel E	Director	Sep 08 '25	Sale	26.75	35,000	936,352	19,932	Sep 10 08:53 PM
Joel Cutler	Director	Sep 08 '25	Proposed Sale	26.75	35,000	936,250		Sep 08 05:55 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,290	Sep 05 05:15 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,162	Sep 05 05:13 PM
Miller Steven Clive	Chief Financial Officer	Sep 03 '25	Option Exercise	0.00	28,475	0	248,875	Sep 05 05:12 PM
Briggs Teresa	Director	Aug 11 '25	Sale	23.56	6,000	141,360	44,879	Aug 13 08:22 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Aug 13 '25	Sale	25.11	50,000	1,255,500	28,347	Aug 13 08:19 PM
NEIL BLUMENTHAL	Director	Aug 13 '25	Proposed Sale	24.41	50,000	1,220,500		Aug 13 04:22 PM
Teresa Briggs	Director	Aug 11 '25	Proposed Sale	23.56	6,000	141,338		Aug 11 04:05 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 21 '25	Sale	24.21	49,600	1,200,816	28,347	Jul 22 06:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	400	9,604	28,347	Jul 22 06:00 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 21 '25	Sale	24.27	74,500	1,808,115	28,475	Jul 22 05:58 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	500	12,005	28,475	Jul 22 05:58 PM
David Gilboa	Director	Jul 18 '25	Proposed Sale	23.45	75,000	1,758,750		Jul 18 04:47 PM
NEIL BLUMENTHAL	Director	Jul 18 '25	Proposed Sale	23.45	50,000	1,172,500		Jul 18 04:47 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 01 '25	Sale	22.04	50,000	1,102,000	28,475	Jul 03 05:00 PM
David Gilboa	Director	Jul 01 '25	Proposed Sale	21.93	50,000	1,096,500		Jul 01 04:32 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,905	Jun 05 08:23 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,777	Jun 05 08:22 PM
Miller Steven Clive	Chief Financial Officer	Jun 03 '25	Option Exercise	0.00	30,175	0	237,092	Jun 05 08:21 PM
Moon Youngme E	Director	May 22 '25	Sale	19.90	33,073	658,153	53,869	May 27 05:13 PM
Moon Youngme E	Director	May 22 '25	Proposed Sale	19.90	33,073	658,153		May 22 04:29 PM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Option Exercise	0.00	27,731	0	216,411	Mar 06 06:02 AM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Sale	23.52	11,684	274,808	204,727	Mar 06 06:02 AM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	52,057	Mar 05 09:57 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Sale	23.51	202,968	4,772,513	24,089	Mar 05 09:57 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	51,928	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 03 '25	Sale	24.40	150,000	3,659,758	22,569	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Sale	23.52	27,967	657,784	23,961	Mar 05 09:56 PM
Steven Clive Miller	Officer	Mar 04 '25	Proposed Sale	20.05	13,700	274,721		Mar 04 09:24 PM
David Abraham Gilboa	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:24 PM
Neil Harris Blumenthal	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:22 PM
NEIL BLUMENTHAL	Director	Mar 03 '25	Proposed Sale	24.73	50,000	1,236,500		Mar 03 05:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 30 '25	Sale	27.61	50,000	1,380,500	12,177	Feb 03 05:59 PM
Sulzberger Gabrielle	Officer	Jan 10 '25	Proposed Sale	26.50	36,942	978,963		Jan 10 04:31 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 02 '25	Sale	25.14	300,000	7,542,000	12,177	Jan 06 06:16 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 02 '25	Sale	25.14	338,004	8,497,447	12,306	Jan 06 06:15 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 03 '25	Sale	25.41	36,996	940,068	12,306	Jan 06 06:15 PM
DAVID GILBOA	Director	Jan 02 '25	Proposed Sale	24.21	550,000	13,315,500		Jan 02 04:24 PM
NEIL BLUMENTHAL	Director	Jan 02 '25	Proposed Sale	24.21	450,000	10,894,500		Jan 02 04:22 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 20 '24	Sale	25.11	144,212	3,621,163	12,306	Dec 26 05:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 20 '24	Sale	25.08	93,946	2,356,166	12,177	Dec 26 05:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 18 '24	Sale	25.09	56,054	1,406,395	12,177	Dec 20 05:01 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 18 '24	Sale	25.09	55,788	1,399,721	12,306	Dec 20 05:00 PM
DAVID ABRAHAM GILBOA	Director	Dec 18 '24	Proposed Sale	24.29	200,000	4,858,000		Dec 18 04:27 PM
NEIL HARRIS BLUMENTHAL	Director	Dec 18 '24	Proposed Sale	24.29	150,000	3,643,500		Dec 18 04:26 PM
Miller Steven Clive	Chief Financial Officer	Dec 11 '24	Sale	23.85	7,016	167,332	182,130	Dec 13 06:20 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 10 '24	Sale	23.50	304,947	7,166,254	12,306	Dec 12 06:25 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 11 '24	Sale	23.84	54,000	1,287,360	12,306	Dec 12 06:25 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 09 '24	Sale	23.65	50,000	1,182,500	12,177	Dec 11 05:42 PM
STEVE MILLER	Officer	Dec 11 '24	Proposed Sale	23.53	7,016	165,086		Dec 11 05:03 PM
DAVID ABRAHAM GILBOA	Director	Dec 11 '24	Proposed Sale	23.53	54,000	1,270,620		Dec 11 04:54 PM
DAVID ABRAHAM GILBOA	Director	Dec 10 '24	Proposed Sale	23.50	304,947	7,166,254		Dec 10 04:25 PM
NEIL BLUMENTHAL	Director	Dec 09 '24	Proposed Sale	23.79	50,000	1,189,500		Dec 09 04:45 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 03 '24	Sale	22.61	36,163	817,645	12,177	Dec 05 07:40 PM
Miller Steven Clive	Chief Financial Officer	Dec 03 '24	Option Exercise	0.00	26,511	0	203,999	Dec 05 07:39 PM
Miller Steven Clive	Chief Financial Officer	Dec 03 '24	Sale	22.61	14,853	335,826	189,146	Dec 05 07:39 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 03 '24	Sale	22.61	36,163	817,645	12,306	Dec 05 07:37 PM
Steven Clive Miller	Officer	Dec 03 '24	Proposed Sale	22.02	14,660	322,813		Dec 03 06:45 PM
Neil Harris Blumenthal	Director, Officer	Dec 03 '24	Proposed Sale	22.02	35,833	789,043		Dec 03 06:43 PM
David Abraham Gilboa	Director, Officer	Dec 03 '24	Proposed Sale	22.02	35,833	789,043		Dec 03 06:42 PM
Warby Parker Impact Foundation	Affiliate	Nov 14 '24	Proposed Sale	21.34	29,762	635,000		Nov 14 02:10 PM

COO Cooper Companies, Inc daily Stock Chart

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB SPY VO IVV RSP VBR XLV VTV

Index	S&P 500	P/E	32.83	EPS (ttm)	2.03	Insider Own	0.66%	Shs Outstand	198.80M	Perf Week	-2.07%
Market Cap	13.26B	Forward P/E	15.12	EPS next Y	4.41	Insider Trans	1.23%	Shs Float	197.50M	Perf Month	-10.22%
Enterprise Value	15.61B	PEG	3.49	EPS next Q	1.11	Inst Own	102.51%	Short Float	3.33%	Perf Quarter	-5.93%
Income	407.80M	P/S	3.28	EPS this Y	10.90%	Inst Trans	0.99%	Short Ratio	2.45	Perf Half Y	-14.22%
Sales	4.05B	P/B	1.59	EPS next Y	7.79%	ROA	3.33%	Short Interest	6.58M	Perf YTD	-27.47%
Book/sh	42.02	P/C	106.14	EPS next 5Y	9.40%	ROE	5.01%	52W High	112.38 -40.66%	Perf Year	-38.45%
Cash/sh	0.63	P/FCF	32.18	EPS past 3/5Y	-49.03% -3.45%	ROIC	3.78%	52W Low	61.78 7.94%	Perf 3Y	-12.87%
Dividend Est.	0.01 (0.02%)	EV/EBITDA	14.05	Sales past 3/5Y	10.05% 7.98%	Gross Margin	62.03%	Volatility	1.94% 2.61%	Perf 5Y	-17.55%
Dividend TTM	-	EV/Sales	3.86	EPS Y/Y TTM	12.94%	Oper. Margin	18.31%	ATR (14)	2.10	Perf 10Y	65.35%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.24	Sales Y/Y TTM	6.35%	Profit Margin	10.08%	RSI (14)	40.72	Recom	1.78
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	-5.82%	SMA20	-5.03%	Beta	1.03	Target Price	83.29
Payout	0.00%	Debt/Eq	0.30	Sales Q/Q	5.73%	SMA50	-6.93%	Rel Volume	1.17	Prev Close	68.46
Employees	16000	LT Debt/Eq	0.29	Earnings	Aug 27 AMC	SMA200	-18.62%	Avg Volume	2.69M	Price	66.68
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.23% -0.34%	Trades		Volume	3,147,673	Change	-2.60%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy	$460 → $405
Apr-08-22	Initiated	Needham	Hold
Jan-03-22	Upgrade	Guggenheim	Neutral → Buy
Sep-03-21	Reiterated	Stifel	Buy	$450 → $475

Show Previous Ratings

Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
09:47AM	Loading…
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
04:05PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
11:48AM	Cooper Cos. Is Falling on Earnings. Why Citi Downgraded the Stock. (Barrons.com)
11:30AM	Top Stock Movers Now: Hormel, Best Buy, Snowflake, and More (Investopedia)
11:20AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
11:12AM	These Stocks Are Moving the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
09:50AM	COO Q2 Deep Dive: Margin Pressures and Product Shifts Drive Cautious Outlook (StockStory)
09:39AM	Loading…
09:39AM	Five Below upgraded, Bill downgraded: Wall Street's top analyst calls (The Fly)
05:46AM	Snowflake shares jump after earnings, and other early market movers (MarketWatch)
05:10AM	These Stocks Are Moving the Most Today: Nvidia, CrowdStrike, Snowflake, Cooper, HP, and More (Barrons.com)
03:06AM	The Cooper Companies Inc (COO) Q3 2025 Earnings Call Highlights: Strong Non-GAAP Earnings ... (GuruFocus.com)
Aug-27-25 06:00PM	Here's What Key Metrics Tell Us About The Cooper Companies (COO) Q3 Earnings (Zacks)
05:25PM	The Cooper Companies (COO) Q3 Earnings Beat Estimates (Zacks)
04:49PM	CooperCompanies's (NASDAQ:COO) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops 11% (StockStory)
04:15PM	CooperCompanies Announces Third Quarter 2025 Results (GlobeNewswire)
Aug-26-25 06:42PM	Analysts Love These 3 Companies Reporting Earnings This Week (MarketBeat)
11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
09:55AM	How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47% (Zacks)
08:22AM	Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
Aug-25-25 11:02PM	CooperCompanies (COO) Q2 Earnings Report Preview: What To Look For (StockStory)
09:51AM	Do Wall Street Analysts Like Cooper Companies Stock? (Barchart)
Aug-22-25 09:15AM	The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
10:00AM	Loading…
Aug-20-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Aug-19-25 08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-14-25 05:30PM	Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:15PM	CooperCompanies to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-12-25 10:58AM	Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies (Zacks)
08:13AM	The Cooper Companies (COO) Traded Down in Q2 Despite Strong Results (Insider Monkey)
Aug-11-25 08:28AM	4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks (Zacks)
Aug-07-25 07:40AM	Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Aug-06-25 05:25PM	McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Aug-05-25 12:16PM	Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings? (Zacks)
12:00PM	All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy (Zacks)
11:40AM	COO or SAUHY: Which Is the Better Value Stock Right Now? (Zacks)
07:36AM	Will GLP-1 Demand Drive MCK's Top Line This Earnings Season? (Zacks)
12:00AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-31-25 08:50AM	Should You Continue to Hold The Cooper Companies (COO)? (Insider Monkey)
Jul-25-25 07:55AM	What to Expect From Cooper Companies' Q3 2025 Earnings Report (Barchart)
Jul-24-25 04:15PM	CooperCompanies Announces Release Date for Third Quarter 2025 (GlobeNewswire)
Jul-22-25 11:56AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory)
Jul-14-25 06:20AM	Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar? (Zacks)
Jul-02-25 08:21AM	COO Stock Declines Despite Strong Core Growth Amid Fertility Woes (Zacks)
Jul-01-25 01:32AM	The 5 Most Interesting Analyst Questions From CooperCompanies's Q1 Earnings Call (StockStory)
Jun-23-25 11:31PM	Medical Devices & Supplies - Diversified Stocks Q1 Teardown: CooperCompanies (NASDAQ:COO) Vs The Rest (StockStory)
09:32AM	HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now? (Zacks)
Jun-19-25 11:20AM	How is Cooper Companies Stock Performance Compared to Other Medical Instruments & Supplies Stocks? (Barchart)
Jun-18-25 09:51AM	Roku upgraded, Sarepta downgraded: Wall Streets top analyst calls (TipRanks)
Jun-07-25 09:47AM	3 Oversold Stocks Flashing Bullish Reversal Signals (MarketBeat)
Jun-05-25 05:37PM	S&P 500 Gains and Losses Today: Tesla Shares Skid as Trump and Musk Tussle Over Budget Bill (Investopedia) +5.58%
Jun-03-25 09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jun-02-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:15AM	Understanding The Cooper Companies (COO) Reliance on International Revenue (Zacks)
08:43AM	COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? (Zacks)
May-30-25 08:47PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -14.61%
02:13PM	Cooper Stock Sinks as Contact Lens Maker Cuts Full-Year Organic Growth Forecast (Investopedia)
12:41PM	Why CooperCompanies (COO) Stock Is Falling Today (StockStory)
11:59AM	Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More (Investopedia)
11:40AM	XRAY vs. COO: Which Stock Should Value Investors Buy Now? (Zacks)
09:32AM	COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down (Zacks)
03:08AM	The Cooper Companies Inc (COO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-29-25 09:10PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
06:00PM	The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	CooperCompanies's (NASDAQ:COO) Q1 Sales Beat Estimates (StockStory)
04:30PM	The Cooper Companies: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Second Quarter 2025 Results (GlobeNewswire)
09:29AM	Reasons to Retain The Cooper Companies Stock in Your Portfolio Now (Zacks)
May-28-25 03:03AM	CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
May-23-25 09:15AM	Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics (Zacks)
May-22-25 09:18AM	Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick (Investing.com)
May-20-25 04:15PM	CooperCompanies' 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet (GlobeNewswire)
07:48AM	Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends (Zacks)
May-15-25 06:35PM	Zomedica Corp. (ZOMDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-14-25 11:40AM	XRAY or COO: Which Is the Better Value Stock Right Now? (Zacks)
07:47AM	The Cooper Companies, Inc. (COO): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-12-25 07:33PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
May-08-25 04:15PM	CooperCompanies to Participate in the William Blair Growth Stock Conference (GlobeNewswire)
07:10AM	Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
12:36AM	3 Cash-Producing Stocks Facing Headwinds (StockStory)
May-07-25 05:45PM	Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-06-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-01-25 07:55AM	Cardinal Health (CAH) Beats Q3 Earnings Estimates (Zacks)
Apr-30-25 04:15PM	CooperCompanies Appoints Barbara Carbone to Board of Directors (GlobeNewswire)
Apr-29-25 04:15PM	CooperCompanies Announces Release Date for Second Quarter 2025 (GlobeNewswire)
Apr-21-25 10:40AM	The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program (PR Newswire)
Apr-17-25 11:17AM	Despite Some Deterioration, Utah Medical Products Is A Solid Play (Seeking Alpha)
Apr-03-25 07:36PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -5.63%
05:04AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-24-25 07:30PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Mar-17-25 03:12PM	The Cooper Companies, Inc. (NASDAQ:COO): An Eye-Catching Proposal (Insider Monkey)
Mar-13-25 07:24PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
05:04AM	Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM
McBride Daniel G	EVP & Chief Operating Officer	Feb 01 '25	Option Exercise	0.00	22,777	0	71,687	Feb 04 04:25 PM
White Albert G III	President & CEO	Feb 01 '25	Option Exercise	0.00	84,264	0	258,941	Feb 04 04:25 PM
Andrews Brian G	EVP, CFO & Treasurer	Feb 01 '25	Option Exercise	0.00	16,850	0	23,464	Feb 04 04:24 PM
Sheffield Holly R	President, CSI	Feb 01 '25	Option Exercise	0.00	17,309	0	45,843	Feb 04 04:24 PM
White Albert G III	President & CEO	Jan 08 '25	Option Exercise	0.00	18,340	0	183,613	Jan 10 04:12 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '25	Option Exercise	0.00	13,328	0	23,763	Jan 10 04:12 PM
Sheffield Holly R	President, CSI	Jan 08 '25	Option Exercise	0.00	4,900	0	30,898	Jan 10 04:11 PM
Ricupati Agostino	SVP & CAO	Jan 08 '25	Option Exercise	0.00	4,472	0	9,328	Jan 10 04:11 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	8,728	0	53,424	Jan 10 04:11 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '25	Option Exercise	0.00	6,420	0	13,034	Jan 10 04:10 PM
Khadder Nicholas	VP, General Counsel & Corp Sec	Jan 08 '25	Option Exercise	0.00	3,492	0	4,369	Jan 10 04:10 PM
White Albert G III	President & CEO	Sep 19 '24	Option Exercise	43.83	114,992	5,040,099	280,265	Sep 20 05:51 PM
White Albert G III	President & CEO	Sep 19 '24	Sale	110.53	114,992	12,710,041	165,273	Sep 20 05:51 PM
Albert G. White III	Officer	Sep 19 '24	Proposed Sale	110.53	114,992	12,709,660		Sep 19 03:53 PM

EYE National Vision Holdings Inc daily Stock Chart

Peers: AMZN WMT COST TGT CVS DG WBA DLTR VSTO FLWS

| Held by: IJR VTI VB IWM VBR VXF FNDA IJS SPSM IWN

Index	RUT	P/E	-	EPS (ttm)	-0.18	Insider Own	2.21%	Shs Outstand	79.17M	Perf Week	-2.09%
Market Cap	1.82B	Forward P/E	27.74	EPS next Y	0.83	Insider Trans	-8.05%	Shs Float	77.45M	Perf Month	-0.99%
Enterprise Value	2.49B	PEG	-	EPS next Q	0.13	Inst Own	107.72%	Short Float	11.98%	Perf Quarter	7.58%
Income	-14.15M	P/S	0.97	EPS this Y	32.81%	Inst Trans	-5.92%	Short Ratio	4.20	Perf Half Y	98.88%
Sales	1.89B	P/B	2.14	EPS next Y	19.99%	ROA	-0.73%	Short Interest	9.28M	Perf YTD	120.63%
Book/sh	10.74	P/C	37.56	EPS next 5Y	23.37%	ROE	-1.77%	52W High	25.67 -10.42%	Perf Year	130.36%
Cash/sh	0.61	P/FCF	32.09	EPS past 3/5Y	- -	ROIC	-0.98%	52W Low	9.56 140.48%	Perf 3Y	-34.59%
Dividend Est.	-	EV/EBITDA	18.56	Sales past 3/5Y	-4.29% 1.12%	Gross Margin	53.78%	Volatility	2.85% 3.44%	Perf 5Y	-41.61%
Dividend TTM	-	EV/Sales	1.32	EPS Y/Y TTM	82.63%	Oper. Margin	2.30%	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.31	Sales Y/Y TTM	-7.25%	Profit Margin	-0.75%	RSI (14)	46.74	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	0.52	EPS Q/Q	373.87%	SMA20	-1.86%	Beta	1.26	Target Price	28.85
Payout	-	Debt/Eq	0.85	Sales Q/Q	7.68%	SMA50	-4.30%	Rel Volume	0.58	Prev Close	23.26
Employees	13411	LT Debt/Eq	0.71	Earnings	Aug 06 BMO	SMA200	38.83%	Avg Volume	2.21M	Price	22.99
IPO	Oct 26, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	31.20% 3.59%	Trades		Volume	1,279,525	Change	-1.16%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-30-25	Initiated	Roth Capital	Buy	$36
Jul-08-25	Upgrade	Barclays	Equal Weight → Overweight	$30
May-09-25	Upgrade	Citigroup	Neutral → Buy	$21
May-07-25	Upgrade	BofA Securities	Underperform → Buy
Oct-17-23	Downgrade	Goldman	Buy → Neutral	$25 → $16
Jul-27-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$30 → $21
Jul-27-23	Downgrade	Citigroup	Buy → Neutral	$28 → $22
May-02-23	Downgrade	Barclays	Overweight → Equal Weight
Mar-31-23	Upgrade	Loop Capital	Hold → Buy	$23
Jan-17-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-07-22	Resumed	Jefferies	Buy	$40 → $45
Jun-27-22	Upgrade	Goldman	Neutral → Buy	$31 → $32
Nov-15-21	Downgrade	Goldman	Buy → Neutral	$59 → $57
Nov-12-21	Downgrade	BofA Securities	Buy → Underperform	$63 → $50
Oct-14-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$70
Aug-27-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$58 → $57
Jan-11-21	Downgrade	Loop Capital	Buy → Hold
Nov-18-20	Downgrade	Berenberg	Buy → Hold	$42
Feb-04-20	Initiated	BMO Capital Markets	Market Perform
Feb-03-20	Initiated	BMO Capital Markets	Market Perform

Show Previous Ratings

Sep-02-25 04:40PM	National Vision, Freshpet, Gray Television, Stratasys, and Erie Indemnity Shares Plummet, What You Need To Know (StockStory)
Aug-20-25 08:00AM	National Vision Announces Participation in Goldman Sachs Global Retailing Conference (Business Wire)
Aug-19-25 09:00AM	America's Best Unveils Major Brand Transformation: VML Relaunches Eye Care Retailer's Identity with the Powerful Message "Every Eye Deserves Better" (PR Newswire)
Aug-13-25 01:35AM	The 5 Most Interesting Analyst Questions From National Vision's Q2 Earnings Call (StockStory)
Aug-12-25 08:22AM	EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up (Zacks)
03:06AM	Loading…
03:06AM	EYE Q2 Deep Dive: Brand Revamp, Pricing Actions, and Managed Care Drive Results (StockStory)
Aug-08-25 03:43PM	2 High-Flying Stocks with Impressive Fundamentals and 1 Facing Challenges (StockStory) -6.33%
Aug-07-25 01:00PM	National Vision (EYE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
Aug-06-25 07:10AM	National Vision (EYE) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:19AM	National Vision (NASDAQ:EYE) Reports Strong Q2, Stock Soars (StockStory)
06:09AM	National Vision: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-05-25 09:44AM	Earnings To Watch: National Vision Holdings Inc (EYE) Reports Q2 2025 Result (GuruFocus.com)
08:00AM	National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation (PR Newswire)
Aug-04-25 11:02PM	National Vision (EYE) Q2 Earnings: What To Expect (StockStory)
11:13AM	Loading…
Aug-01-25 11:13AM	Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View (Zacks)
Jul-30-25 09:40AM	Peloton upgraded, Booking downgraded: Wall Street's top analyst calls (The Fly)
08:21AM	National Vision Releases Annual Sustainability Report Highlighting 2024 Progress (Business Wire)
Jul-29-25 08:02AM	National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships (Business Wire)
Jul-25-25 09:40AM	Are Consumer Staples Stocks Lagging National Vision (EYE) This Year? (Zacks)
Jul-23-25 08:00AM	National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call (Business Wire)
Jul-15-25 12:38AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Jul-13-25 11:34PM	Q1 Specialty Retail Earnings: National Vision (NASDAQ:EYE) Earns Top Marks (StockStory)
Jul-11-25 09:15AM	National Vision Holdings, Inc. (EYE) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jul-09-25 09:40AM	Is National Vision (EYE) Stock Outpacing Its Consumer Staples Peers This Year? (Zacks)
01:31AM	The Top 5 Analyst Questions From National Vision's Q1 Earnings Call (StockStory)
Jul-08-25 01:50PM	National Vision (EYE) Stock Is Up, What You Need To Know (StockStory) +6.00%
Jun-24-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:35AM	Is This the Right Time to Hold EYE Stock in Your Portfolio? (Zacks)
Jun-19-25 12:33AM	1 Russell 2000 Stock with Competitive Advantages and 2 to Keep Off Your Radar (StockStory)
09:59AM	Loading…
Jun-10-25 09:59AM	EYE Q1 Earnings Call: National Vision Discusses Transformation Strategy, Leadership Transition, and Tariff Impact (StockStory)
12:37AM	1 Cash-Producing Stock to Research Further and 2 to Be Wary Of (StockStory)
Jun-06-25 11:31AM	Why Is National Vision (EYE) Up 25.1% Since Last Earnings Report? (Zacks)
Jun-02-25 09:50AM	Here's Why National Vision (EYE) is a Strong Momentum Stock (Zacks) +6.97%
May-29-25 12:35AM	1 High-Flying Stock with Exciting Potential and 2 to Think Twice About (StockStory)
May-22-25 12:00AM	3 Reasons EYE is Risky and 1 Stock to Buy Instead (StockStory)
May-21-25 04:05PM	National Vision Announces Participation in William Blair Growth Stock Conference (Business Wire)
May-20-25 11:35AM	Art Basel Qatar to Debut in Doha in February (WWD)
May-17-25 07:00AM	MarketBeat Week in Review - 05/12 - 05/16 (MarketBeat)
May-16-25 07:30AM	3 Small-Cap Stocks With Room to Run Despite Tariff Headwinds (MarketBeat)
May-15-25 04:05PM	National Vision Announces Settlement of 2025 Convertible Senior Notes (Business Wire)
09:50AM	Why National Vision (EYE) is a Top Momentum Stock for the Long-Term (Zacks)
08:47AM	Keep Your EYE on This Stock, It Just Got a Rare Double Upgrade (MarketBeat)
May-14-25 03:44PM	National Vision Just Skyrocketed. A Big Shareholder Says It Isnt Done. (Barrons.com)
May-08-25 07:54AM	EYE Q1 Earnings and Revenues Beat, Gross Margin Up, Stock Surges (Zacks) +6.85%
03:15AM	National Vision Holdings Inc (EYE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-07-25 04:12PM	National Vision's Q1 results earns double upgrade at BofA (Seeking Alpha) +17.10%
07:15AM	National Vision (EYE) Beats Q1 Earnings and Revenue Estimates (Zacks)
06:13AM	National Vision: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results (Business Wire)
Apr-29-25 09:55AM	National Vision announces CEO transition (Chain Store Age)
06:00AM	National Vision Appoints Alex Wilkes as CEO (Business Wire)
Apr-28-25 09:40AM	Is Coca-Cola Europacific Partners (CCEP) Stock Outpacing Its Consumer Staples Peers This Year? (Zacks)
Apr-24-25 08:00AM	National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call (Business Wire)
Apr-10-25 08:56AM	National Vision (EYE) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
Apr-09-25 08:39AM	Is it the Right Time to Add EYE Stock to Your Portfolio Now? (Zacks) +9.38%
05:17AM	New Strong Buy Stocks for April 9th (Zacks)
Apr-08-25 05:12AM	Specialty Retail Stocks Q4 Earnings: National Vision (NASDAQ:EYE) Firing on All Cylinders (StockStory)
Apr-07-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-01-25 12:00PM	National Vision (EYE) Upgraded to Strong Buy: Here's Why (Zacks)
Mar-31-25 09:50AM	Here's Why National Vision (EYE) is a Strong Momentum Stock (Zacks)
08:50AM	Fast-paced Momentum Stock National Vision (EYE) Is Still Trading at a Bargain (Zacks)
Mar-28-25 11:30AM	National Vision (EYE) Up 7.2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-27-25 07:14AM	National Vision Stock Rises 28.2% YTD: Will the Rally Continue? (Zacks)
Mar-26-25 09:40AM	Is National Vision (EYE) Outperforming Other Consumer Staples Stocks This Year? (Zacks)
09:28AM	National Vision Names VML Agency of Record (Business Wire)
Mar-24-25 11:40AM	EYE or CL: Which Is the Better Value Stock Right Now? (Zacks)
Mar-20-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Mar-17-25 04:05PM	National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors (Business Wire)
Mar-11-25 09:45AM	National Vision Awards $12,500 to Three Optometry Students in 10th Annual Scholarship Program (Business Wire)
08:00AM	National Vision Announces Participation in UBS Global Consumer and Retail Conference (Business Wire)
Mar-10-25 09:40AM	Has National Vision (EYE) Outpaced Other Consumer Staples Stocks This Year? (Zacks)
Mar-04-25 09:40AM	National Vision (EYE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Mar-03-25 09:50AM	Why National Vision (EYE) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-27-25 02:06AM	National Vision Holdings Inc (EYE) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst ... (GuruFocus.com)
12:14AM	Q4 2024 National Vision Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-26-25 03:24PM	National Vision (EYE) Stock Trades Up, Here Is Why (StockStory) +11.63%
07:10AM	National Vision (EYE) Reports Q4 Loss (Zacks)
06:35AM	National Vision (NASDAQ:EYE) Posts Better-Than-Expected Sales In Q4, Stock Jumps 17.9% (StockStory)
06:21AM	National Vision: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results (Business Wire)
05:59AM	National Vision Appoints Christopher Laden as Chief Financial Officer (Business Wire)
Feb-25-25 10:43AM	National Vision Holdings Inc (EYE) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
08:08AM	National Vision (EYE) Q4 Earnings: What To Expect (StockStory)
Feb-18-25 09:02AM	National Visions 20/20 Quest Foundation Grants $25,000 to Optometry Giving Sight to Support Global Vision Care Initiatives (Business Wire)
Feb-12-25 08:00AM	National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call (Business Wire)
Jan-28-25 12:10PM	Why National Vision (EYE) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-22-25 08:50AM	Despite Fast-paced Momentum, National Vision (EYE) Is Still a Bargain Stock (Zacks)
Jan-17-25 03:12PM	National Vision on hunt for new CFO; announces leadership changes (Chain Store Age)
12:31PM	National Vision announces promotions as CFO departs (Chain Store Age)
Jan-16-25 04:09PM	Mueller Water Products Appoints Melissa Rasmussen as Chief Financial Officer (GlobeNewswire)
04:05PM	National Vision Announces Leadership Changes (Business Wire)
Jan-14-25 04:03AM	3 Reasons to Sell EYE and 1 Stock to Buy Instead (StockStory)
Jan-13-25 04:05AM	Specialty Retail Stocks Q3 Results: Benchmarking Petco (NASDAQ:WOOF) (StockStory)
Jan-06-25 04:07AM	Q3 Earnings Recap: National Vision (NASDAQ:EYE) Tops Specialty Retail Stocks (StockStory)
Dec-26-24 04:04AM	Q3 Earnings Highlights: Leslie's (NASDAQ:LESL) Vs The Rest Of The Specialty Retail Stocks (StockStory)
Dec-16-24 03:32AM	Unpacking Q3 Earnings: Tractor Supply (NASDAQ:TSCO) In The Context Of Other Specialty Retail Stocks (StockStory)
Dec-06-24 11:31AM	National Vision (EYE) Down 4.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-07-24 06:34AM	National Vision Holdings Reports Revenue Growth Amid Challenges (TipRanks)
Nov-06-24 06:23AM	National Vision Reaffirms FY23 Outlook - Update (RTT News)

National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FAHS L READE	Executive Chairman	Aug 28 '25	Sale	24.33	137,400	3,343,174	544,795	Aug 29 04:16 PM
FAHS L READE	Officer	Aug 28 '25	Proposed Sale	24.33	137,400	3,343,335		Aug 28 04:16 PM
Molony Megan	SVP, CHIEF MERCH. & MC OFFICER	May 15 '25	Option Exercise	15.07	12,206	183,944	16,181	May 16 04:30 PM
Molony Megan	SVP, CHIEF MERCH. & MC OFFICER	May 14 '25	Sale	18.90	3,900	73,710	3,975	May 16 04:30 PM
Moore Patrick R.	Former Officer	May 16 '25	Proposed Sale	19.13	15,983	305,751		May 16 02:29 PM
Molony Megan	Officer	May 15 '25	Proposed Sale	18.60	10,581	196,807		May 15 01:11 PM
Acharya Ravi	SVP, Chief Technology Officer	May 13 '25	Sale	18.75	12,000	225,060	11,700	May 14 04:37 PM
Molony Megan	Officer	May 14 '25	Proposed Sale	18.90	3,900	73,710		May 14 11:53 AM
Acharya Ravi	Officer	May 13 '25	Proposed Sale	18.75	12,000	225,060		May 13 03:34 PM
Rasmussen Melissa	Former Officer	May 07 '25	Proposed Sale	15.51	28,869	447,698		May 07 05:03 PM
VanDette Joseph	SVP, Chief Marketing Officer	Mar 01 '25	Sale	12.71	1,179	14,985	10,444	Mar 04 04:50 PM

BLCO Bausch + Lomb Corp daily Stock Chart

Peers: JNJ ALGN NVO TEVA PFE MRK CRL DHR ABT EXAS

| Held by: MGMT DFAX DFIC GUSA

Index	-	P/E	-	EPS (ttm)	-0.77	Insider Own	89.69%	Shs Outstand	353.80M	Perf Week	1.20%
Market Cap	5.38B	Forward P/E	19.17	EPS next Y	0.79	Insider Trans	0.01%	Shs Float	36.47M	Perf Month	7.20%
Enterprise Value	10.13B	PEG	-	EPS next Q	0.16	Inst Own	10.14%	Short Float	8.85%	Perf Quarter	22.11%
Income	-273.00M	P/S	1.10	EPS this Y	-18.49%	Inst Trans	2.74%	Short Ratio	4.24	Perf Half Y	0.00%
Sales	4.89B	P/B	0.83	EPS next Y	54.27%	ROA	-2.02%	Short Interest	3.23M	Perf YTD	-15.89%
Book/sh	18.20	P/C	19.76	EPS next 5Y	17.05%	ROE	-4.22%	52W High	21.69 -29.97%	Perf Year	-4.65%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	- -	ROIC	-2.40%	52W Low	10.45 45.36%	Perf 3Y	-3.56%
Dividend Est.	-	EV/EBITDA	18.22	Sales past 3/5Y	8.36% 4.87%	Gross Margin	54.08%	Volatility	2.63% 2.40%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.07	EPS Y/Y TTM	40.43%	Oper. Margin	2.60%	ATR (14)	0.41	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.98	Sales Y/Y TTM	8.81%	Profit Margin	-5.58%	RSI (14)	59.29	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.55	EPS Q/Q	59.16%	SMA20	2.75%	Beta	0.63	Target Price	14.96
Payout	-	Debt/Eq	0.77	Sales Q/Q	5.10%	SMA50	6.23%	Rel Volume	0.41	Prev Close	15.32
Employees	13500	LT Debt/Eq	0.77	Earnings	Jul 30 BMO	SMA200	2.40%	Avg Volume	761.80K	Price	15.19
IPO	May 06, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.36% 1.46%	Trades		Volume	310,268	Change	-0.85%

Date	Action	Analyst	Rating Change	Price Target Change
May-02-25	Reiterated	H.C. Wainwright	Buy	$20 → $15
Mar-28-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$24 → $15
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$24 → $22
Dec-02-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$19
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform	$19 → $25
Jul-10-24	Initiated	Raymond James	Outperform	$19
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16 → $18
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$19 → $17
Dec-12-23	Initiated	Stifel	Hold	$16
Oct-03-23	Resumed	Evercore ISI	Outperform	$20
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$20
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight	$17
Sep-12-22	Initiated	H.C. Wainwright	Buy	$21
Jul-26-22	Initiated	RBC Capital Mkts	Outperform	$22
Jun-24-22	Initiated	Evercore ISI	Outperform	$21
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Wells Fargo	Overweight	$23
May-31-22	Initiated	Morgan Stanley	Equal-Weight	$22
May-31-22	Initiated	JP Morgan	Neutral	$20

Show Previous Ratings

Sep-11-25 07:00AM	Bausch + Lomb Announces Publication of enVista Envy Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial (Business Wire)
Sep-09-25 07:00AM	Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA in Alleviating Discomfort in Symptomatic Contact Lens Wearers (Business Wire)
Sep-08-25 06:56PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
04:30PM	Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why (StockStory)
07:00AM	Bausch + Lomb Launches ASANA Gas Permeable Lenses in the United States (Business Wire)
12:41AM	Loading…
Sep-05-25 12:41AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Aug-22-25 02:25PM	Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know (StockStory)
Aug-20-25 11:31PM	Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO) (StockStory)
Aug-18-25 05:48PM	Icahn representations resign Bausch + Lomb board after agreement termination (Reuters)
05:01PM	Bausch + Lomb Announces Board Changes (Business Wire)
Aug-14-25 07:15AM	Bausch + Lomb to Participate in Upcoming Investor Conferences (Business Wire)
Aug-12-25 11:55PM	5 Revealing Analyst Questions From Bausch + Lomb's Q2 Earnings Call (StockStory)
11:48PM	BLCO Q2 Deep Dive: Product Launches Offset Margin Pressures, Management Highlights Pipeline Investments (StockStory)
Aug-07-25 12:38AM	1 Stock Under $50 to Target This Week and 2 We Ignore (StockStory)
Jul-30-25 03:05PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -6.42%
12:16PM	Loading…
12:16PM	Why Bausch + Lomb (BLCO) Stock Is Down Today (StockStory)
09:30AM	Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:34AM	Bausch + Lomb's (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:04AM	Bausch + Lomb: Q2 Earnings Snapshot (Associated Press Finance)
06:57AM	Bausch + Lomb Announces Second-Quarter 2025 Results (Business Wire)
05:38AM	New Strong Sell Stocks for July 30th (Zacks)
Jul-29-25 09:27AM	Bausch & Lomb Corp (TSX:BLCO) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:00AM	Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY Preservative Free Redness Reliever Eye Drops (Business Wire)
Jul-28-25 11:09PM	Bausch + Lomb (BLCO) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-24-25 05:04AM	New Strong Sell Stocks for July 24th (Zacks)
Jul-23-25 10:00AM	Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-22-25 08:45AM	Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity (PR Newswire)
Jul-21-25 09:13AM	Ophthalmic Implants Market: Focused Insights (2025-2030) Featuring Alcon, Carl Zeiss, Bausch + Lomb, Johnson & Johnson and 20 Other Industry Leaders (GlobeNewswire)
Jul-20-25 11:31PM	Medical Devices & Supplies - Specialty Stocks Q1 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers (StockStory)
07:00AM	Loading…
Jul-01-25 07:00AM	Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye (Business Wire)
Jun-30-25 06:58AM	Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13 (Business Wire)
Jun-26-25 04:30PM	Bausch + Lomb Announces Closing of Upsized 675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility (Business Wire)
Jun-25-25 07:42AM	The Top 5 Analyst Questions From Bausch + Lomb's Q1 Earnings Call (StockStory)
Jun-23-25 11:58AM	Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June (Insider Monkey)
Jun-18-25 04:30PM	Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering (Business Wire)
Jun-10-25 08:48AM	Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement (Business Wire) +5.01%
Jun-04-25 06:59AM	Bausch + Lomb Launches Blink Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States (Business Wire)
May-27-25 12:47PM	Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know (StockStory)
May-22-25 07:30AM	Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference (Business Wire)
12:00AM	3 Reasons to Avoid BLCO and 1 Stock to Buy Instead (StockStory)
May-21-25 04:30PM	Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results (Business Wire)
09:36AM	Anthony Pompliano on taking his SPAC public: Focused on buying a cash-flow positive business (CNBC TV)
06:59AM	Bausch + Lomb Launches New LUMIFY Preservative Free Redness Reliever Eye Drops in the United States (Business Wire)
May-14-25 06:59AM	Bausch + Lomb Launches Zenlens CHROMA HOA in the United States (Business Wire)
May-08-25 12:37AM	3 Profitable Stocks Walking a Fine Line (StockStory)
May-07-25 09:30AM	Bausch + Lomb gets European nod for intraocular lens (Seeking Alpha)
07:00AM	Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens (Business Wire)
May-01-25 03:08AM	Bausch & Lomb Corp (BLCO) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Challenges (GuruFocus.com)
Apr-30-25 04:40PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -15.74%
11:02AM	Bausch + Lomb Corporation (BLCO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
09:30AM	Bausch + Lomb (BLCO) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Bausch + Lomb (BLCO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:57AM	Bausch + Lomb Announces First-Quarter 2025 Results (Business Wire)
Apr-29-25 03:10AM	Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-24-25 10:01AM	CVS Health (CVS) Earnings Expected to Grow: Should You Buy? (Zacks) +9.03%
07:00AM	Bausch + Lomb Returning enVista Intraocular Lenses to Market Following Voluntary Recall (Business Wire)
Apr-23-25 07:23PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
11:40AM	BLCO or DHR: Which Is the Better Value Stock Right Now? (Zacks)
10:01AM	Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-25 10:08AM	Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts? (Insider Monkey)
Apr-21-25 04:39PM	Bausch Health Companies Inc (BHC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
07:00AM	Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs (Business Wire)
Apr-18-25 05:16AM	3 Reasons to Sell BLCO and 1 Stock to Buy Instead (StockStory)
Apr-13-25 12:47AM	PCMM: Why This Private Credit ETF Deserves A Spot On Your Watchlist (Seeking Alpha)
Apr-10-25 09:05AM	Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last? (Zacks) -9.66%
Apr-08-25 06:46PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -7.33% +13.91%
Apr-07-25 05:02AM	Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment (StockStory)
Apr-03-25 03:39PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -9.48%
Mar-28-25 02:33PM	Bausch + Lomb Stock Sinks on 'Voluntary Recall' of Some Implantable Eye Lenses (Investopedia) -5.80%
01:33PM	Mag 7 slide, gold rises, Bausch + Lomb recall: Market Minute (Yahoo Finance Video)
01:20PM	Why Bausch + Lomb (BLCO) Shares Are Plunging Today (StockStory)
Mar-27-25 02:54PM	Why Bausch + Lomb (BLCO) Stock Is Nosediving (StockStory)
07:00AM	Bausch + Lomb Announces Voluntary Recall of enVista Aspire, enVista Envy and Certain enVista Monofocal Intraocular Lenses (Business Wire)
Mar-26-25 07:45AM	Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 (Business Wire)
Mar-17-25 07:00AM	Bausch + Lomb Launches Arise Orthokeratology Lens System in the United States (Business Wire)
Feb-23-25 02:00PM	How DOGE's 'transparency' could be applied to healthcare (Yahoo Finance Video)
Feb-20-25 02:41AM	Q4 2024 Bausch + Lomb Corp Earnings Call (Thomson Reuters StreetEvents)
02:03AM	Bausch & Lomb Corp (BLCO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-19-25 01:22PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
08:53AM	Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent (Yahoo Finance)
07:51AM	Bausch + Lomb to shake up contact lenses with deal off the table (Yahoo Finance Video)
07:21AM	Bausch + Lombs (NYSE:BLCO) Q4: Beats On Revenue (StockStory)
06:58AM	Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance (Business Wire)
04:28AM	Bausch & Lomb Corp (TSX:BLCO) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-18-25 08:03AM	Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-06-25 07:17PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -9.52%
07:00AM	Bausch + Lomb Provides Update on Potential Sale (Business Wire)
Jan-22-25 07:00AM	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19 (Business Wire)
Jan-13-25 07:00AM	Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences (Business Wire)
06:00AM	Bausch + Lomb Launches enVista Aspire Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union (Business Wire)
Jan-12-25 09:30AM	Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20? (Insider Monkey)
Jan-07-25 07:00AM	Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign and Fundraising Challenge (Business Wire)
Jan-03-25 06:46AM	Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI (TipRanks)
Jan-02-25 07:00AM	Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-13-24 10:45AM	BofA rates Bausch & Lomb underperform with lower buyout chances (Investing.com)
Dec-12-24 07:00AM	Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb (ACCESSWIRE)
07:00AM	Bausch + Lomb Responds to Rumors of a Potential Sale (Business Wire)
Dec-11-24 02:14PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -12.06%
06:59AM	Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities (Business Wire)

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAUNDERS BRENT L	CEO and Chairman of the Board	May 22 '25	Buy	11.28	22,000	248,072	719,156	May 27 08:16 AM
VON ESCHENBACH ANDREW C.	Director	May 02 '25	Buy	11.76	1,695	19,925	41,748	May 06 04:30 PM

STAA Staar Surgical Co daily Stock Chart

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR IWM VTI VB SPSM IWO VXF VBK IJT SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.93	Insider Own	0.56%	Shs Outstand	49.28M	Perf Week	-0.86%
Market Cap	1.37B	Forward P/E	105.04	EPS next Y	0.26	Insider Trans	-	Shs Float	49.28M	Perf Month	-1.81%
Enterprise Value	1.22B	PEG	-	EPS next Q	0.18	Inst Own	109.07%	Short Float	8.10%	Perf Quarter	58.83%
Income	-95.27M	P/S	6.12	EPS this Y	-411.90%	Inst Trans	1.83%	Short Ratio	2.55	Perf Half Y	59.10%
Sales	224.45M	P/B	4.06	EPS next Y	139.36%	ROA	-20.05%	Short Interest	3.99M	Perf YTD	14.04%
Book/sh	6.83	P/C	7.23	EPS next 5Y	28.53%	ROE	-25.55%	52W High	38.60 -28.24%	Perf Year	-8.10%
Cash/sh	3.83	P/FCF	-	EPS past 3/5Y	- -	ROIC	-25.61%	52W Low	13.50 105.19%	Perf 3Y	-70.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.85% 15.89%	Gross Margin	70.53%	Volatility	1.68% 1.83%	Perf 5Y	-44.57%
Dividend TTM	-	EV/Sales	5.45	EPS Y/Y TTM	-667.81%	Oper. Margin	-46.49%	ATR (14)	0.63	Perf 10Y	271.81%
Dividend Ex-Date	-	Quick Ratio	4.05	Sales Y/Y TTM	-32.59%	Profit Margin	-42.45%	RSI (14)	64.54	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-329.24%	SMA20	-0.13%	Beta	0.84	Target Price	24.86
Payout	-	Debt/Eq	0.12	Sales Q/Q	-55.23%	SMA50	18.63%	Rel Volume	0.25	Prev Close	28.08
Employees	1211	LT Debt/Eq	0.11	Earnings	Aug 06 AMC	SMA200	32.92%	Avg Volume	1.56M	Price	27.70
IPO	Jul 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	39.43% 9.43%	Trades		Volume	384,909	Change	-1.35%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight	$91
Oct-13-22	Initiated	Mizuho	Buy	$85

Show Previous Ratings

Sep-11-25 12:19PM	Exclusive: Shareholder revolt threatens Alcons takeover of STAAR Surgical (Investing.com)
Sep-02-25 05:41PM	STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger (Business Wire)
12:36AM	1 Healthcare Stock with Solid Fundamentals and 2 We Avoid (StockStory)
Aug-25-25 12:31AM	1 Russell 2000 Stock with Exciting Potential and 2 Facing Challenges (StockStory)
Aug-19-25 12:08AM	Predicting the Next Rule Breaker Buyout (Motley Fool)
01:17AM	Loading…
Aug-13-25 01:17AM	Takeover Agreement with Alcon Sparks Sharp Weekly Gains for STAAR Surgical (Insider Monkey)
Aug-11-25 09:15AM	Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations (Zacks)
Aug-06-25 08:23PM	STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 Numbers (StockStory)
06:30PM	Staar Surgical (STAA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:20PM	Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:24PM	Staar Surgical: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2025 Results (Business Wire)
Aug-05-25 03:50PM	Why Are STAAR Surgical (STAA) Shares Soaring Today (StockStory) +46.13%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:01AM	Staar Surgical Co (STAA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
09:27AM	Loading…
09:27AM	Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition (Benzinga)
07:47AM	Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical (Medical Device Network)
07:10AM	Henry Schein (HSIC) Q2 Earnings Lag Estimates (Zacks)
07:03AM	Alcon to acquire STAAR Surgical for about $1.5B (MedTech Dive)
01:43AM	Alcon to buy eye health firm STAAR Surgical for $1.5 bln (Investing.com)
01:01AM	Alcon Agrees to Acquire STAAR Surgical (Business Wire)
Jul-31-25 10:03PM	STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025 (Business Wire)
Jul-21-25 01:15PM	STAAR Surgical (STAA) Stock Is Up, What You Need To Know (StockStory)
Jul-14-25 12:07AM	3 Reasons to Sell STAA and 1 Stock to Buy Instead (StockStory)
Jul-11-25 12:36AM	1 Healthcare Stock on Our Buy List and 2 to Approach with Caution (StockStory)
Jul-02-25 01:32AM	STAAR Surgical's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-25-25 09:28AM	STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors (Business Wire)
Jun-17-25 11:31PM	Q1 Earnings Roundup: STAAR Surgical (NASDAQ:STAA) And The Rest Of The Medical Devices & Supplies - Specialty Segment (StockStory)
Jun-11-25 06:24AM	STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook (StockStory)
May-22-25 07:00AM	STAAR Surgical Announces Participation in Upcoming Investor Conferences (Business Wire)
12:50PM	Loading…
May-16-25 12:50PM	STAAR Surgical plans $30m share buyback despite China market woes (Medical Device Network) +5.08%
07:00AM	STAAR Surgical Announces $30 Million Share Repurchase Authorization (Business Wire)
May-08-25 03:39AM	Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing ... (GuruFocus.com)
May-07-25 11:51PM	STAAR Surgical projects significant China revenue rebound in Q3 2025 amid tariff mitigation and new product launch (Seeking Alpha)
11:51PM	STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:00PM	Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:45PM	Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:41PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports First Quarter 2025 Results (Business Wire)
Apr-29-25 09:06AM	3 Dawdling Stocks That Concern Us (StockStory)
Apr-24-25 05:00PM	STAAR Surgical Announces Changes to Board of Directors (Business Wire)
Apr-23-25 07:00AM	STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025 (Business Wire)
Apr-11-25 03:07PM	Couchbase, Staar Surgical, Zymeworks, and More Stocks See Action From Activist Investors (Barrons.com) +7.84%
05:15AM	Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4 (StockStory)
Apr-08-25 09:34PM	STAAR Surgical Company (STAA): Among Stocks Insiders Bought in April After Trump's Tariff Rollout (Insider Monkey) -6.51% +5.17%
05:04AM	Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA) (StockStory)
Mar-17-25 06:30PM	STAAR Surgical Announces Realignment of Leadership Structure (Business Wire)
Mar-07-25 08:01AM	3 Stocks Under $50 in Hot Water (StockStory)
Mar-04-25 11:00AM	Staar Surgical names Stephen Farrell as CEO (MedTech Dive) +7.77%
Feb-28-25 04:03AM	A Look Back at Medical Devices & Supplies - Specialty Stocks Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack (StockStory)
Feb-26-25 04:45PM	STAAR Surgical Announces Leadership Transition (Business Wire)
06:02AM	Staar Surgical to lay off 115 people in California (MedTech Dive)
Feb-19-25 04:51AM	What To Expect From Staar Surgical Co (STAA) Q4 2024 Earnings (GuruFocus.com) +6.86%
Feb-12-25 09:44AM	Tesla, Instacart initiated: Wall Street's top analyst calls (The Fly) -24.68%
05:14AM	Staar Surgical: Q4 Earnings Snapshot (Associated Press Finance)
02:13AM	Staar Surgical Co (STAA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities (GuruFocus.com)
Feb-11-25 04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results (Business Wire)
Jan-13-25 07:00AM	STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025 (Business Wire)
Jan-04-25 07:50AM	Staar Surgical price target lowered to $39 from $49 at BTIG (TipRanks)
Nov-25-24 07:00AM	STAAR Surgical to Participate in BTIG Ophthalmology Day (Business Wire) +7.01%
Nov-13-24 10:05AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
07:00AM	STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024) (Business Wire)
Nov-04-24 09:15AM	A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts (Zacks)
05:15AM	STAAR Surgical and Lucy Bronze, MBE, See Eye to Eye on Vision Correction (PR Newswire)
Nov-02-24 09:00AM	Staar Surgical Co (STAA) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amidst Challenges (GuruFocus.com)
Oct-30-24 10:21PM	CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results (Business Wire)
05:35PM	Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:33PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2024 Results (Business Wire)
Oct-29-24 09:11AM	What To Expect From Staar Surgical Co (STAA) Q3 2024 Earnings (GuruFocus.com)
Oct-23-24 07:00AM	STAAR Surgical to Report Third Quarter Results on October 30, 2024 (Business Wire)
Oct-07-24 09:55AM	Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher (Zacks)
Sep-27-24 09:55AM	Wall Street Analysts Predict a 43.93% Upside in Staar Surgical (STAA): Here's What You Should Know (Zacks) +9.92%
Sep-23-24 07:00AM	STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand (Business Wire)
Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-16-24 12:00PM	Staar Surgical (STAA) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Sep-06-24 01:01PM	Baillie Gifford Reduces Stake in Staar Surgical Co (GuruFocus.com)
Aug-13-24 10:48AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
Aug-12-24 09:15AM	Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention (Zacks)
Aug-07-24 11:53PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) +11.03%
08:00PM	Staar Surgical (STAA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:22PM	Staar Surgical: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2024 Results (Business Wire)
Jul-31-24 07:00AM	STAAR Surgical to Report Second Quarter Results on August 7, 2024 (Business Wire)
Jul-30-24 07:00AM	STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jun-27-24 01:25PM	Staar Surgical Stock Earns RS Rating Upgrade (Investor's Business Daily)
04:01AM	Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock? (Zacks)
Jun-05-24 07:00AM	STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 11:06AM	Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock (Zacks)
May-08-24 11:06AM	STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript (Insider Monkey) -12.07%
10:17AM	Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating (MT Newswires)
07:59AM	Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating (MT Newswires)
03:43AM	Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ... (GuruFocus.com)
May-07-24 11:54PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:58PM	Staar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue Growth (GuruFocus.com)
05:26PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	STAAR Surgical Reports First Quarter 2024 Results (Business Wire)
04:01PM	STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Wei	Director	Aug 12 '25	Option Exercise	0.00	20,967	0	24,510	Aug 13 06:39 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	1,750	47,025		Aug 05 06:38 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	13,491	362,523		Aug 05 06:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 08 '25	Buy	15.32	178,127	2,729,095	13,510,391	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 09 '25	Buy	15.08	8,200	123,676	13,518,591	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 10 '25	Buy	15.18	900	13,658	13,519,491	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 04 '25	Buy	15.91	497,631	7,917,191	13,194,210	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 03 '25	Buy	16.97	209,535	3,555,138	12,696,579	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 07 '25	Buy	15.61	138,054	2,155,174	13,332,264	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 02 '25	Buy	17.43	31,780	553,925	12,487,044	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 31 '25	Buy	17.46	22,189	387,360	12,455,264	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 26 '25	Buy	17.50	101,633	1,778,517	12,421,324	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 28 '25	Buy	17.47	8,131	142,014	12,433,075	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 27 '25	Buy	17.48	3,620	63,294	12,424,944	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 21 '25	Buy	17.74	102,400	1,816,545	12,285,395	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 25 '25	Buy	17.44	34,296	598,177	12,319,691	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 20 '25	Buy	17.96	108,720	1,952,992	12,182,995	Mar 20 07:51 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 18 '25	Buy	17.54	93,124	1,633,291	12,074,275	Mar 20 07:51 PM
Foust Warren	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	8,175	0	26,088	Mar 14 07:24 PM
Michna Magda	Chief Clinical, Regulatory,	Mar 12 '25	Option Exercise	0.00	6,177	0	18,554	Mar 14 07:21 PM
SISITSKY NATHANIEL	General Counsel	Mar 12 '25	Option Exercise	0.00	5,827	0	27,762	Mar 14 07:20 PM
Williams Patrick F.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	8,153	0	56,242	Mar 14 07:19 PM
Williams Patrick F.	Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	4,061	0	48,089	Mar 11 08:40 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '25	Option Exercise	0.00	5,689	0	44,028	Mar 11 08:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 04 '25	Buy	17.24	27,953	481,849	11,981,151	Mar 06 07:07 PM
FARRELL STEPHEN C	President & CEO	Mar 05 '25	Option Exercise	6.95	20,000	138,900	35,156	Mar 06 05:47 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 27 '25	Buy	17.05	259,316	4,420,106	11,548,753	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 03 '25	Buy	16.64	249,503	4,151,214	11,953,198	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 28 '25	Buy	17.45	154,942	2,704,235	11,703,695	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 12 '25	Buy	14.96	259,616	3,883,255	11,137,623	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 13 '25	Buy	15.84	115,282	1,825,514	11,252,905	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 14 '25	Buy	15.49	36,532	565,998	11,289,437	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 14 '25	Buy	21.46	21,155	454,086	10,869,786	Jan 16 07:20 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 16 '25	Buy	21.50	8,221	176,753	10,878,007	Jan 16 07:20 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 16 '24	Buy	24.24	53,500	1,297,084	10,821,931	Dec 18 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 18 '24	Buy	24.33	23,000	559,493	10,848,631	Dec 18 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 17 '24	Buy	24.58	3,700	90,963	10,825,631	Dec 18 07:00 PM

Open in Screener

RXST

RxSight Inc

Sep 12 • 04:00PM ET

9.31

-0.11 -1.17 %

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM IWO VXF SCHA VTWO XHE VHT DFAS FFOX

Index	RUT	P/E	-	EPS (ttm)	-0.80	Insider Own	8.40%	Shs Outstand	40.91M	Perf Week	4.72%
Market Cap	380.93M	Forward P/E	-	EPS next Y	-1.17	Insider Trans	-0.20%	Shs Float	37.48M	Perf Month	12.03%
Enterprise Value	165.15M	PEG	-	EPS next Q	-0.37	Inst Own	94.05%	Short Float	14.53%	Perf Quarter	-34.76%
Income	-32.25M	P/S	2.59	EPS this Y	-71.59%	Inst Trans	9.17%	Short Ratio	3.91	Perf Half Y	-63.08%
Sales	147.06M	P/B	1.37	EPS next Y	4.18%	ROA	-10.50%	Short Interest	5.45M	Perf YTD	-72.92%
Book/sh	6.80	P/C	1.67	EPS next 5Y	-8.67%	ROE	-11.66%	52W High	57.53 -83.82%	Perf Year	-82.59%
Cash/sh	5.56	P/FCF	-	EPS past 3/5Y	26.50% -	ROIC	-11.17%	52W Low	6.32 47.31%	Perf 3Y	-31.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	83.64% 128.61%	Gross Margin	73.12%	Volatility	6.86% 5.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.12	EPS Y/Y TTM	20.87%	Oper. Margin	-28.92%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.70	Sales Y/Y TTM	27.68%	Profit Margin	-21.93%	RSI (14)	54.22	Recom	3.09
Dividend Gr. 3/5Y	- -	Current Ratio	13.93	EPS Q/Q	-82.99%	SMA20	4.34%	Beta	1.17	Target Price	8.89
Payout	-	Debt/Eq	0.04	Sales Q/Q	-3.58%	SMA50	9.62%	Rel Volume	0.53	Prev Close	9.42
Employees	498	LT Debt/Eq	0.04	Earnings	Aug 07 AMC	SMA200	-55.63%	Avg Volume	1.39M	Price	9.31
IPO	Jul 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.08% -3.32%	Trades		Volume	732,995	Change	-1.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-15-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$9
Jul-10-25	Downgrade	Jefferies	Buy → Hold	$9
Jul-09-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$9
Jul-09-25	Downgrade	Oppenheimer	Outperform → Perform
Jul-09-25	Downgrade	BTIG Research	Buy → Neutral
May-19-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$25
Apr-15-25	Initiated	Piper Sandler	Neutral	$18
Apr-09-25	Downgrade	UBS	Buy → Neutral	$16
Apr-04-25	Downgrade	JP Morgan	Overweight → Underweight	$40 → $17
Apr-03-25	Downgrade	BofA Securities	Buy → Underperform	$36 → $22
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36

Show Previous Ratings

Sep-09-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire) +9.40%
Sep-05-25 04:09PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Sep-04-25 03:59PM	Investors Urged to Contact Levi & Korsinsky for Information Before September 22, 2025 - RxSight, Inc. (RXST) (Newsfile)
Aug-25-25 04:05PM	RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire) -7.22%
Aug-22-25 08:45AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +6.30%
04:05PM	Loading…
Aug-14-25 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-13-25 05:14PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile) +13.06%
Aug-12-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +10.53%
Aug-07-25 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -7.70%
04:05PM	RxSight, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 08:05AM	RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors (GlobeNewswire)
Aug-01-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Jul-31-25 04:15PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-30-25 04:02PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-25-25 04:54PM	RxSight, Inc. (RXST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
04:05PM	Loading…
Jul-24-25 04:05PM	RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-09-25 03:00AM	RxSight Inc (RXST) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Market Challenges (GuruFocus.com) -37.84%
Jul-08-25 04:05PM	RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Jul-04-25 11:40AM	FMS vs. RXST: Which Stock Is the Better Value Option? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
May-23-25 08:32AM	Do Options Traders Know Something About RxSight Stock We Don't? (Zacks)
May-20-25 04:10PM	RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum (GlobeNewswire)
10:55AM	Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued (Insider Monkey)
May-08-25 03:31AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ... (GuruFocus.com) -11.21%
May-07-25 11:04PM	RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript (Seeking Alpha) +6.81%
07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
04:05PM	Loading…
Apr-30-25 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
Apr-04-25 11:46AM	JP Morgan downgrades RxSight on market, competitive pressures (Investing.com)
09:40AM	Block upgraded, Nvidia downgraded: Wall Streets top analyst calls (TipRanks)
03:00AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... (GuruFocus.com)
Apr-03-25 10:39PM	Preliminary Q1 2025 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) -37.94%
05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
03:54PM	RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) (Seeking Alpha)
12:59PM	RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock (GuruFocus.com)
07:32AM	RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges (Benzinga)
Apr-02-25 08:00PM	RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-25-25 04:05PM	RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-26-25 02:15AM	RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-25 05:55PM	RxSight, Inc. (RXST) Misses Q4 Earnings Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance (GlobeNewswire)
01:36AM	What To Expect From RxSight Inc (RXST) Q4 2024 Earnings (GuruFocus.com)
Feb-11-25 04:10PM	RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire) +6.08%
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weinberg Eric	See remarks	Jun 02 '25	Option Exercise	3.93	188,002	738,848	195,351	Jun 03 06:18 PM
Thunen Shelley B	See remarks	Apr 14 '25	Option Exercise	4.34	7,792	33,806	38,354	Apr 15 08:57 PM
Fountain Tamara	Director	Mar 12 '25	Sale	25.71	7,000	180,002	24,793	Mar 13 04:46 PM
TAMARA R FOUNTAIN	Director	Mar 12 '25	Proposed Sale	25.71	7,000	180,002		Mar 12 04:02 PM
Maniar Shweta	Director	Jan 22 '25	Sale	30.87	3,519	108,618	7,383	Jan 27 04:40 PM
Maniar Shweta	Director	Jan 22 '25	Proposed Sale	30.87	3,519	108,618		Jan 22 03:56 PM
Corley Jesse Anderson	Director	Jan 16 '25	Buy	31.13	1,767	55,004	3,210	Jan 17 07:08 PM
Corley Jesse Anderson	Director	Jan 15 '25	Buy	31.18	1,443	45,000	1,443	Jan 17 07:08 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Option Exercise	15.08	3,105	46,823	45,351	Dec 03 06:38 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Sale	46.08	3,105	143,078	42,246	Dec 03 06:38 PM
ILYA GOLDSHLEGER	Officer	Nov 29 '24	Proposed Sale	46.08	3,105	143,078		Nov 29 01:29 PM
Maniar Shweta	Director	Nov 26 '24	Sale	45.88	3,782	173,518	10,902	Nov 26 07:26 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Sale	45.88	3,100	142,228	42,246	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Sale	45.00	3,100	139,500	42,246	Nov 26 07:25 PM
ILYA GOLDSHLEGER	Officer	Nov 26 '24	Proposed Sale	45.88	3,100	142,228		Nov 26 04:13 PM
Maniar Shweta	Director	Nov 26 '24	Proposed Sale	45.88	3,782	173,518		Nov 26 02:45 PM
ILYA GOLDSHLEGER	Officer	Nov 22 '24	Proposed Sale	45.00	3,100	139,500		Nov 22 04:15 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Option Exercise	15.08	4,875	73,515	47,121	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Sale	46.00	4,875	224,250	42,246	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Sale	45.00	3,100	139,502	42,246	Nov 18 09:50 PM
ILYA GOLDSHLEGER	Officer	Nov 18 '24	Proposed Sale	45.00	3,100	139,502		Nov 18 04:29 PM
ILYA GOLDSHLEGER	Officer	Nov 15 '24	Proposed Sale	46.00	4,875	224,250		Nov 15 04:18 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Option Exercise	15.08	1,330	20,056	43,576	Nov 14 07:42 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Sale	46.13	1,330	61,356	42,246	Nov 14 07:42 PM
Corley Jesse Anderson	Director	Nov 12 '24	Buy	45.37	11,111	504,079	468,571	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	44.84	5,795	259,841	38,438	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	45.00	5,570	250,650	474,141	Nov 14 07:14 PM
ILYA GOLDSHLEGER	Officer	Nov 12 '24	Proposed Sale	46.13	1,330	61,356		Nov 12 05:38 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 08 04:00 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Sale	55.00	3,100	170,495	42,246	Nov 08 04:00 PM
ILYA GOLDSHLEGER	Officer	Nov 07 '24	Proposed Sale	55.00	3,100	170,494		Nov 07 04:14 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 05 04:05 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Sale	51.05	3,100	158,247	42,246	Nov 05 04:05 PM
ILYA GOLDSHLEGER	Officer	Nov 04 '24	Proposed Sale	51.05	3,100	158,247		Nov 04 04:17 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 31 05:22 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Sale	51.91	3,105	161,171	42,246	Oct 31 05:22 PM
LYA GOLDSHLEGER	Officer	Oct 30 '24	Proposed Sale	51.91	3,105	161,171		Oct 30 04:28 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Sale	50.64	3,100	156,993	42,246	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Sale	49.79	3,100	154,360	42,246	Oct 28 08:55 PM
ILYA GOLDSHLEGER	Officer	Oct 28 '24	Proposed Sale	50.64	3,100	156,993		Oct 28 04:15 PM
ILYA GOLDSHLEGER	Officer	Oct 25 '24	Proposed Sale	49.79	3,100	154,360		Oct 25 04:15 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 22 08:17 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Sale	49.68	3,100	154,001	42,246	Oct 22 08:17 PM
ILYA GOLDSHLEGER	Officer	Oct 22 '24	Proposed Sale	49.68	3,100	154,001		Oct 22 04:16 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Sale	50.09	3,105	155,533	42,246	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Sale	49.78	3,100	154,318	42,246	Oct 18 05:23 PM
ILYA GOLDSHLEGER	Officer	Oct 18 '24	Proposed Sale	50.09	3,105	155,533		Oct 18 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 16 '24	Proposed Sale	49.78	3,100	154,317		Oct 16 04:16 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Sale	50.19	3,100	155,594	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Sale	50.09	3,100	155,268	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Sale	48.82	3,105	151,596	42,246	Oct 15 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 14 '24	Proposed Sale	50.09	3,100	155,268		Oct 15 08:23 AM
ILYA GOLDSHLEGER	Officer	Oct 11 '24	Proposed Sale	50.19	3,100	155,593		Oct 11 04:17 PM
ILYA GOLDSHLEGER	Officer	Oct 10 '24	Proposed Sale	48.82	3,105	151,595		Oct 10 04:11 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Sale	48.26	3,100	149,612	42,246	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Sale	48.01	3,100	148,824	42,246	Oct 08 06:00 PM
ILYA GOLDSHLEGER	Officer	Oct 08 '24	Proposed Sale	48.26	3,100	149,612		Oct 08 04:19 PM
ILYA GOLDSHLEGER	Officer	Oct 04 '24	Proposed Sale	48.01	3,100	148,824		Oct 04 04:23 PM
Thunen Shelley B	See remarks	Oct 01 '24	Option Exercise	16.00	15,000	240,000	45,443	Oct 02 04:11 PM
Thunen Shelley B	See remarks	Oct 01 '24	Sale	48.45	15,000	726,730	30,443	Oct 02 04:11 PM
SHELLEY B THUNEN	Officer	Oct 01 '24	Proposed Sale	48.45	15,000	726,729		Oct 01 04:24 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Option Exercise	15.08	3,105	46,823	45,351	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Sale	49.29	3,105	153,054	42,246	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Sale	49.02	3,100	151,947	42,246	Sep 30 08:05 PM
ILYA GOLDSHLEGER	Officer	Sep 30 '24	Proposed Sale	49.02	3,100	151,946		Sep 30 04:14 PM
ILYA GOLDSHLEGER	Officer	Sep 26 '24	Proposed Sale	49.29	3,105	153,054		Sep 26 04:09 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Sale	53.19	3,100	164,901	42,246	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Sale	52.67	3,100	163,263	42,246	Sep 23 06:48 PM
ILYA GOLDSHLEGER	Officer	Sep 23 '24	Proposed Sale	52.67	3,100	163,263		Sep 23 04:08 PM
ILYA GOLDSHLEGER	Officer	Sep 20 '24	Proposed Sale	53.19	3,100	164,901		Sep 20 04:08 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 18 04:41 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Sale	56.11	3,100	173,944	42,246	Sep 18 04:41 PM
ILYA GOLDSHLEGER	Officer	Sep 17 '24	Proposed Sale	56.11	3,100	173,943		Sep 17 04:15 PM

LUCY Innovative Eyewear Inc daily Stock Chart

Peers: SONY LOGI GRMN BBY VSTO TBCH BB KOSS NTGR UEIC

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-3.24	Insider Own	63.39%	Shs Outstand	4.57M	Perf Week	-0.26%
Market Cap	8.71M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	0.00%	Shs Float	1.67M	Perf Month	-4.75%
Enterprise Value	-0.09M	PEG	-	EPS next Q	-0.49	Inst Own	4.12%	Short Float	9.01%	Perf Quarter	-28.79%
Income	-7.73M	P/S	4.40	EPS this Y	54.72%	Inst Trans	2.52%	Short Ratio	0.07	Perf Half Y	-50.26%
Sales	1.98M	P/B	0.77	EPS next Y	85.53%	ROA	-78.12%	Short Interest	0.15M	Perf YTD	-61.28%
Book/sh	2.47	P/C	0.98	EPS next 5Y	-	ROE	-83.04%	52W High	11.16 -82.93%	Perf Year	-62.87%
Cash/sh	1.95	P/FCF	-	EPS past 3/5Y	16.39% -25.35%	ROIC	-68.24%	52W Low	1.57 21.32%	Perf 3Y	-96.01%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	33.31% 131.48%	Gross Margin	18.25%	Volatility	8.67% 6.04%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-0.05	EPS Y/Y TTM	70.61%	Oper. Margin	-404.93%	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.46	Sales Y/Y TTM	29.30%	Profit Margin	-390.88%	RSI (14)	45.85	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.70	EPS Q/Q	64.89%	SMA20	-1.61%	Beta	3.20	Target Price	5.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	87.65%	SMA50	-6.03%	Rel Volume	0.08	Prev Close	1.93
Employees	11	LT Debt/Eq	0.00	Earnings	Aug 14 AMC	SMA200	-45.06%	Avg Volume	2.03M	Price	1.90
IPO	Aug 15, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	14.29% -42.08%	Trades		Volume	155,460	Change	-1.30%

Sep-10-25 08:30AM	Innovative Eyewear, Inc. Announces New Verbal Translation Feature for the Lucyd ChatGPT App (PR Newswire) +5.72%
Aug-14-25 04:30PM	Innovative Eyewear Inc. Reports Q2 2025 Unaudited Financial Results (PR Newswire) +10.00% -6.82%
Aug-11-25 08:00AM	Innovative Eyewear Announces Participation in Key Industry and Investor Events in Q3 2025 (PR Newswire)
Jul-21-25 08:30AM	Innovative Eyewear Launches Reebok Smartglasses in New Channels (PR Newswire)
Jun-24-25 03:27PM	Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants (PR Newswire) -9.64%
07:00AM	Loading…
Jun-23-25 07:00AM	Innovative Eyewear, Inc. Announces $4.8 Million of Gross Proceeds Raised from Warrant Transactions (PR Newswire) -29.46%
Jun-20-25 08:30AM	Innovative Eyewear Partners with Smartech to Showcase Reebok Smart Eyewear at Smartech's New Flagship Opening in Times Square (PR Newswire) +54.82%
May-29-25 08:00AM	Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App (PR Newswire) +15.51%
May-13-25 05:49PM	Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results (PR Newswire) +5.88% +46.46%
May-05-25 08:00AM	Innovative Eyewear Partners with Eye Recommend, Expanding Smart Eyewear Access Across 600+ Independent Optometry Stores (PR Newswire)
Apr-28-25 08:00AM	Innovative Eyewear Launches Reebok Smart Eyewear (PR Newswire)
Apr-23-25 08:30AM	Innovative Eyewear, Inc. Highlights Smart Eyewear Competitive Pricing Edge Amid Eyeglass Industry Cost Pressures Due to Tariffs (PR Newswire) +5.65%
Apr-11-25 09:00AM	Innovative Eyewear, Inc. Announces Exercise of Warrants for $1.8 Million Gross Proceeds (PR Newswire) -52.53%
Apr-10-25 08:30AM	Innovative Eyewear enters EU market, receives EU Certification for Lucyd Armor Safety Glasses (PR Newswire) +102.04%
Apr-07-25 08:30AM	Innovative Eyewear Launches 'Moonbeam': Smart Eyewear Designed for Everyday Life (PR Newswire) -6.06%
08:30AM	Loading…
Mar-25-25 08:30AM	Innovative Eyewear Inc. Reports Full Year 2024 Financial Results (PR Newswire)
Feb-26-25 08:30AM	Innovative Eyewear Announces Secure Walkie Channels for the Lucyd App, Unlocking New Potential for Corporations and Teams Worldwide (PR Newswire) +6.39%
Feb-05-25 08:30AM	Innovative Eyewear Takes Center Stage at MIDO 2025 with Reebok Smart Eyewear Line Launch (PR Newswire)
Jan-30-25 08:30AM	Innovative Eyewear Announces Key Retail Partnership with Micro Center (PR Newswire)
Jan-16-25 08:30AM	Innovative Eyewear Announces Lucyd Armor Safety Certification for Canada (PR Newswire)
Jan-15-25 08:30AM	Innovative Eyewear Announces Participation in Key Industry Events in Q1 2025 (PR Newswire)
Dec-16-24 10:55PM	New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming (ACCESS Newswire) +6.71% -7.82%
Nov-25-24 08:30AM	Innovative Eyewear Launches Four New Lucyd Lyte Smart Glasses with Enhanced Features (PR Newswire)
Nov-13-24 08:00AM	Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-05-24 08:30AM	Innovative Eyewear, Inc. Announces Lucyd Smart Eyewear Now Sold at Nebraska Furniture Mart (PR Newswire)
Oct-29-24 08:30AM	Innovative Eyewear Launches First ANSI-Certified Smart Safety Glasses for All-day Wear (PR Newswire) +28.93%
Oct-24-24 08:30AM	Innovative Eyewear, Inc. Announces Notice of Patent Allowance on Modular Smart Eyewear Technology (PR Newswire) -5.40%
Oct-14-24 08:30AM	Innovative Eyewear Launches First-Ever Generative AI Eyewear Fashion Show (PR Newswire)
Oct-02-24 12:07PM	Innovative Eyewear Announces New Retail Partners (PR Newswire) +18.67%
Sep-25-24 08:20PM	Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan (PR Newswire) -9.46%
08:00AM	Loading…
Sep-23-24 08:00AM	Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds (PR Newswire) -16.13%
Sep-17-24 08:30AM	Innovative Eyewear to Unveil ANSI-Certified Smart Safety Eyewear at Vision Expo West (PR Newswire) +25.00%
Sep-05-24 08:30AM	Innovative Eyewear Secures Distribution Deal for Gulf Cooperation Council (GCC) Countries (PR Newswire)
Sep-04-24 05:49PM	Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants (PR Newswire) +5.35%
Sep-03-24 08:39AM	Innovative Eyewear, Inc. Announces Exercise of Warrants (PR Newswire) -10.74%
Aug-29-24 08:00AM	Innovative Eyewear, Inc. Announces Lucyd Smart Eyewear Now Sold on Target.com (PR Newswire) +53.78%
Aug-21-24 08:00AM	Innovative Eyewear, Inc. Announces Strategic Alliance with Geenee Inc. to Deliver Next-gen Smart Eyewear Retail Experiences (PR Newswire)
Aug-13-24 08:00AM	Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results (PR Newswire) +13.33%
Aug-01-24 10:22AM	Innovative Eyewear Inc. Regains Compliance with Nasdaq Listing Requirements (Newsfile)
Jul-18-24 08:00AM	Innovative Eyewear Inc. Announces the First Walkie-Talkie Feature for Smart Eyewear (Newsfile) -16.53%
Jun-14-24 08:30AM	Innovative Eyewear Inc. Announces Significant Progress in International Expansion (PR Newswire)
Jun-13-24 08:30AM	Innovative Eyewear, Inc. Launches Bixby App to Enable ChatGPT on its Smart Eyewear (PR Newswire) -12.89%
Jun-07-24 06:40AM	7 Growth Stocks to Buy in June for Great Gains (InvestorPlace) -11.12%
Jun-03-24 08:00AM	Innovative Eyewear, Inc. to Participate in 'Charting the Course: Navigating the Intersection of TMT and Business in the AI Era' Conference, June 4 - 5, 2024 (PR Newswire)
May-30-24 07:47AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -16.75%
May-29-24 04:15PM	Innovative Eyewear, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire) +131.46%
12:15PM	PLTR Stock Alert: Palantir Strikes New Deal With Eaton (InvestorPlace)
11:58AM	Why Is Innovative Eyewear (LUCY) Stock Up 188% Today? (InvestorPlace)
09:00AM	Innovative Eyewear, Inc. Launches Eddie Bauer Smart Eyewear with ChatGPT (PR Newswire)
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-28-24 02:43PM	Innovative Eyewear, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire) -58.29%
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-24-24 04:02PM	What's Going on With Innovative Eyewear (LUCY) Stock Today? (InvestorPlace) +428.49%
07:16AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-14-24 01:53PM	LUCY Stock Earnings: Innovative Eyewear Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +7.93%
08:30AM	Innovative Eyewear Inc. Reports First Quarter 2024 Financial Results (PR Newswire)
May-01-24 05:00PM	Innovative Eyewear, Inc. Announces Closing of $1.025 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules (PR Newswire) +9.04%
04:30PM	7 Penny Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 08:00AM	Innovative Eyewear, Inc. Announces $1.025 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire)
Apr-25-24 08:32AM	Innovative Eyewear, Inc. Partners with New Look Vision Group to Provide Smart Eyewear in Canada (PR Newswire)
Apr-24-24 08:30AM	Innovative Eyewear, Inc. Announces New Patent Filings and Receipt of Notices of Allowance on Smart Safety Eyewear (PR Newswire)
Apr-18-24 08:30AM	Innovative Eyewear, Inc. Signs UK Football Legend and Media Personality Micah Richards as Brand Ambassador (PR Newswire)
Apr-17-24 08:30AM	Innovative Eyewear, Inc. Signs Distribution Partnership with Windsor Eyes, Inc. (PR Newswire)
Mar-25-24 01:53PM	LUCY Stock Earnings: Innovative Eyewear Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:30AM	Innovative Eyewear Inc. Reports 2023 Financial Results (PR Newswire)
Feb-01-24 09:00AM	Innovative Eyewear, Inc. Commences Shipping of Nautica Smart Eyewear Collection (PR Newswire)
Jan-22-24 08:00AM	Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024 (GlobeNewswire)
Jan-11-24 08:00AM	Innovative Eyewear, Inc. 2023 Year-end Review (PR Newswire) -8.67%
Jan-10-24 08:00AM	Innovative Eyewear, Inc. Receives Notice of Allowance for Fourteen Patent Applications (PR Newswire) +6.06%
Jan-05-24 10:04AM	Innovative Eyewear, Inc. and IngenioSpec LLC Announce License Agreement (PR Newswire) -6.84%
Dec-14-23 08:30AM	Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador (PR Newswire) -9.50%
Dec-13-23 09:00AM	Global Smart Eyewear Market Size Expected to Reach $10.6 Billion By 2024 (PR Newswire)
Dec-12-23 08:30AM	Innovative Eyewear, Inc. Announces the 2.0 Release of its Android ChatGPT App for Smart Eyewear (PR Newswire) -10.80%
Dec-11-23 08:30AM	Innovative Eyewear, Inc. Launches Nautica Smart Eyewear Under Multi-Year, Global Licensing Agreement with Authentic Brands Group (PR Newswire) +11.11%
Nov-16-23 07:00AM	Innovative Eyewear, Inc. Launches Upgraded Charging Dock for ChatGPT-enabled Smart Eyewear (PR Newswire)
Oct-17-23 07:00AM	Innovative Eyewear, Inc. Launches the Lyte XL Smart Eyewear Collection (PR Newswire) +12.69%
Oct-03-23 08:00AM	Innovative Eyewear, Inc. (Nasdaq: LUCY) to Present at 8th Annual Dawson James Conference (GlobeNewswire) -6.04%
Sep-22-23 03:05PM	Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. (GlobeNewswire)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-11-23 07:00AM	Innovative Eyewear, Inc. Announces New Patent Filing on Self-adjusting Spring Hinges for Smartglasses (PR Newswire) +8.40%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-14-23 07:00AM	Innovative Eyewear, Inc. Announces the 2.0 Release of its ChatGPT App for Smart Eyewear (PR Newswire)
Aug-03-23 09:25AM	Innovative Eyewear, Inc. Interim Company Update (GlobeNewswire)
08:30AM	Innovative Eyewear Discusses Smart Eyewear Market, Product Differentiation, Brand Partnerships and Value Catalysts in New CEO Video Interview on Planet MicroCap (ACCESSWIRE)
08:00AM	Harrison Gross CEO, Innovative Eyewear Inc. Discusses Smart Eyewear a Recent Partnership, and More with Steve Macalbry of BestGrowthStocks.Com (News Direct)
Aug-02-23 02:26PM	Innovative Eyewear CEO says company is leading innovation in smart eyewear; unveils new Blueshift Lens (News Direct)
Aug-01-23 08:00AM	Innovative Eyewear, Inc. Launches the Lucyd Blueshift Lens for Enhanced Eye Protection and Comfort (PR Newswire)
Jun-30-23 07:00AM	Innovative Eyewear, Inc. Announces Miami Swim Week Runway Show and New Summer Lens Collection (PR Newswire)
Jun-28-23 07:00AM	Innovative Eyewear, Inc. Announces Partnership with PRIVATO Duty Free (PR Newswire)
Jun-26-23 02:44PM	Innovative Eyewear Announces Closing of $4.7 Million Public Offering (PR Newswire)
Jun-22-23 08:15AM	Innovative Eyewear Announces Pricing of $4.7 Million Public Offering (GlobeNewswire) -27.34%
Jun-20-23 07:00AM	Innovative Eyewear, Inc. Announces Multi-Year, Global Licensing Agreement With Authentic Brands Group for Reebok® Smart Eyewear (PR Newswire) -10.96%
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE) -10.00%
Apr-14-23 07:00AM	Innovative Eyewear Inc. Hosts Its First Smart Eyewear Fashion Show in Miami to Introduce Lucyd® Lyte 2.0 Collection With ChatGPT Integration (PR Newswire)
Apr-12-23 08:52AM	Is Innovative Eyewear (NASDAQ:LUCY) In A Good Position To Invest In Growth? (Simply Wall St.)
07:00AM	Innovative Eyewear, Inc. Files Patent For ChatGPT Enabled Smart Eyewear (PR Newswire)
Apr-11-23 07:00AM	Innovative Eyewear, Inc. Launches The First ChatGPT Enabled Smart Eyewear (PR Newswire) +201.37%
Mar-02-23 07:00AM	Innovative Eyewear, Inc. Launches New Titanium Styles of Lucyd Lyte® 2.0 Audio Eyewear (PR Newswire)
Feb-23-23 11:18AM	Innovative Eyewear Inc. Launches Lucyd Lyte 2.0 the Next Generation of Smart Eyewear on Amazon (PR Newswire)
Feb-07-23 02:00AM	Innovative Eyewear, Inc. Launches Lucyd Lyte 2.0 Audio Eyewear Line (PR Newswire) +22.35%

Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cohen David Eric	Officer	Sep 10 '25	Proposed Sale	2.12	760	1,611		Sep 10 02:40 PM
Dabrowski Konrad	Officer	Aug 19 '25	Proposed Sale	1.95	2,596	5,058		Aug 19 01:22 PM
Abondano Joaquin	Officer	Aug 19 '25	Proposed Sale	1.95	1,485	2,890		Aug 19 01:17 PM
Gross Harrison R.	Officer	Aug 19 '25	Proposed Sale	1.96	3,009	5,894		Aug 19 01:12 PM
Cohen David Eric	Officer	Aug 19 '25	Proposed Sale	1.99	2,225	4,422		Aug 19 11:02 AM
Gayle Oswald	Officer	Aug 19 '25	Proposed Sale	1.99	1,670	3,317		Aug 19 10:58 AM
Abondano Joaquin	Officer	May 14 '25	Proposed Sale	2.96	1,264	3,735		May 15 09:15 AM
Gayle Oswald	Officer	Apr 10 '25	Proposed Sale	2.78	3,579	9,935		Apr 10 05:03 PM
Cohen David Eric	Officer	Apr 10 '25	Proposed Sale	2.73	1,519	4,139		Apr 10 04:46 PM
Gross Harrison R.	Officer	Apr 10 '25	Proposed Sale	2.55	1,440	3,666		Apr 10 04:38 PM
Galkin Vladimir	10% Owner	Sep 23 '24	Buy	9.08	200,792	1,822,973	1,000,000	Sep 26 08:31 AM
Galkin Vladimir	10% Owner	Sep 20 '24	Buy	10.31	70,000	721,472	813,245	Sep 24 03:28 PM
Galkin Vladimir	10% Owner	Sep 20 '24	Sale	10.61	14,037	148,896	799,208	Sep 24 03:28 PM
Galkin Vladimir	10% Owner	Sep 19 '24	Buy	8.91	297,443	2,649,148	785,573	Sep 24 02:51 PM
Galkin Vladimir	10% Owner	Sep 19 '24	Sale	9.07	42,328	384,100	743,245	Sep 24 02:51 PM
Galkin Vladimir	10% Owner	Sep 18 '24	Buy	7.79	128,130	997,896	548,130	Sep 24 12:25 PM
Galkin Vladimir	10% Owner	Sep 18 '24	Sale	8.17	60,000	490,400	488,130	Sep 24 12:25 PM
Galkin Vladimir	10% Owner	Sep 17 '24	Buy	7.12	346,736	2,469,387	678,483	Sep 24 12:00 PM
Galkin Vladimir	10% Owner	Sep 17 '24	Sale	7.27	258,483	1,879,632	420,000	Sep 24 12:00 PM

WRBY

Warby Parker Inc

COO

Cooper Companies, Inc

EYE

National Vision Holdings Inc

BLCO

Bausch + Lomb Corp

STAA

Staar Surgical Co

RXST

RxSight Inc

LUCY

Innovative Eyewear Inc

Upgrade your FINVIZ experience